Coriolis Pharma is a globally operating contract research and development organization and partner for drug product development, analytical and manufacturing services across a wide range of therapeutic modalities, including antibodies, peptides, therapeutic proteins, cell and gene therapy, and nucleic acids. The company focuses on liquid and lyophilized drug products, providing services under both R&D and GMP conditions, with expert scientists designing platform and custom services to accelerate and derisk the path to market.

No comments available.
Leave your rating & comment